Das Mouli, Swain Rakesh, Nandi Souvik, Habibullah Sk, Mallick Subrata
Department of Pharmaceutics, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, India.
Drug Dev Ind Pharm. 2025 Jul;51(7):720-734. doi: 10.1080/03639045.2025.2499880. Epub 2025 May 7.
Febuxostat (FBX) has been crystallized using bentonite dispersion as an antisolvent, and characterized by heat of fusion and heat of transition rule for possible polymorphic transformation and improved dissolution.
Polymorphic transformation may exhibit significant alteration of melting temperature, solubility, dissolution rate, and stability. FBX is known for polymorphic/hydrate/solvate transformation in many forms wherein stable form has hardly been reported.
Aqueous bentonite dispersion was used as antisolvent for crystallization of FBX and characterized by heat of fusion and heat of transition rule, and the effect of bentonite concentration on drug dissolution has also been confirmed.
Monotropic and enantiotropic relationships between the pair of polymorphs have been established with the help of transition enthalpy and transition entropy rule. Energy-entropy interplay showed that the transition occurred above the melting temperature indicating the monotropic relation between the FBX crystal pairs (from A to Q). Fourier Transform Infrared spectroscopy (FTIR) and X-ray diffraction (XRD) studies also confirmed the transformation of A (pure FBX) to Q form and its stability (40 °C, 75%RH, 3 months). The crystallite size was estimated from the graphical plot of major important XRD peaks using the least square method of altered Scherrer equation which is supposed to minimize the error associated with the original Scherrer equation. Williamson-Hall equation was used properly for determining strain from the positive slope avoiding misperception of negative slope.
Prepared form Q was found stable and displayed drug dissolution in an improved and controlled manner.
使用膨润土分散体作为抗溶剂使非布司他(FBX)结晶,并通过熔融热和转变热规则对其进行表征,以研究可能的多晶型转变并改善其溶解性。
多晶型转变可能会使熔点、溶解度、溶解速率和稳定性发生显著变化。FBX以多种形式的多晶型/水合物/溶剂化物转变而闻名,其中稳定形式鲜有报道。
使用水性膨润土分散体作为抗溶剂使FBX结晶,并通过熔融热和转变热规则进行表征,同时也证实了膨润土浓度对药物溶解的影响。
借助转变焓和转变熵规则建立了这对多晶型物之间的单向和双向关系。能量-熵相互作用表明,转变发生在熔点以上,这表明FBX晶体对(从A到Q)之间存在单向关系。傅里叶变换红外光谱(FTIR)和X射线衍射(XRD)研究也证实了A(纯FBX)向Q形式的转变及其稳定性(40°C,75%相对湿度,3个月)。使用改进的谢乐方程的最小二乘法从主要重要XRD峰的图形图中估计微晶尺寸,该方法旨在最小化与原始谢乐方程相关的误差。威廉姆森-霍尔方程被正确用于从正斜率确定应变,避免对负斜率的误解。
发现制备的Q形式稳定,并以改进和可控的方式显示药物溶解。